KIRSKE DAVID (EVP, Chief Financial Officer) sold 75.9% of their position (54.04K shares) of CTI BIOPHARMA CORP on the open market
Open‑market sale worth $324.6K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
common stock
Shares
+13.17K
Price / share
$0.95
Trade value
$12.50K
% of position
common stock
Shares
−13.17K
Price / share
$6.00
Trade value
$79.04K
% of position
common stock
Shares
+214.00
Price / share
$5.11
Trade value
$1.09K
% of position
common stock
Shares
+12K
Price / share
$0.95
Trade value
$11.39K
% of position
common stock
Shares
−12K
Price / share
$6.00
Trade value
$72K
% of position
common stock
Shares
+800.00
Price / share
$0.95
Trade value
$759.12
% of position
common stock
Shares
−800.00
Price / share
$6.00
Trade value
$4.80K
% of position
common stock
Shares
+1.05K
Price / share
$0.95
Trade value
$993.50
% of position
common stock
Shares
−1.05K
Price / share
$6.01
Trade value
$6.29K
% of position
common stock
Shares
+27.02K
Price / share
$0.95
Trade value
$25.64K
% of position
common stock
Shares
−27.02K
Price / share
$6.01
Trade value
$162.42K
% of position
Net shares
+214.00
Net value
-$272.19K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| common stock Direct | 12/29/2022 | M · Option Exercise | +13.17K | $0.95 | $12.50K | 77.9% | 16.91K | 30.09K |
| common stock Direct | 12/29/2022 | S · Sale | −13.17K | $6.00 | $79.04K | 43.8% | 30.09K | 16.91K |
| common stock Direct | 12/30/2022 | A · Award | +214.00 | $5.11 | $1.09K | 1.3% | 16.91K | 17.13K |
| common stock Direct | 12/30/2022 | M · Option Exercise | +12K | $0.95 | $11.39K | 70.1% | 17.13K | 29.13K |
| common stock Direct | 12/30/2022 | S · Sale | −12K | $6.00 | $72K | 41.2% | 29.13K | 17.13K |
| common stock Direct | 12/30/2022 | M · Option Exercise | +800.00 | $0.95 | $759.12 | 4.7% | 17.13K | 17.93K |
| common stock Direct | 12/30/2022 | S · Sale | −800.00 | $6.00 | $4.80K | 4.5% | 17.93K | 17.13K |
| common stock Direct | 12/30/2022 | M · Option Exercise | +1.05K | $0.95 | $993.50 | 6.1% | 17.13K | 18.17K |
| common stock Direct | 12/30/2022 | S · Sale | −1.05K | $6.01 | $6.29K | 5.8% | 18.17K | 17.13K |
| common stock Direct | 1/3/2023 | M · Option Exercise | +27.02K | $0.95 | $25.64K | 157.8% | 17.13K | 44.15K |
| common stock Direct | 1/3/2023 | S · Sale | −27.02K | $6.01 | $162.42K | 61.2% | 44.15K | 17.13K |
| Total | +214.00 | -$272.19K | ||||||
Non-Qualified Stock Option (right to buy)
Common Stock
13.17K shares
Shares
−13.17K
Strike price
0.9489
Held after
311.08K
Exercisable
—
Non-Qualified Stock Option (right to buy)
Common Stock
12K shares
Shares
−12K
Strike price
0.9489
Held after
299.08K
Exercisable
—
Non-Qualified Stock Option (right to buy)
Common Stock
800.00 shares
Shares
−800.00
Strike price
0.9489
Held after
298.28K
Exercisable
—
Non-Qualified Stock Option (right to buy)
Common Stock
1.05K shares
Shares
−1.05K
Strike price
0.9489
Held after
297.24K
Exercisable
—
Non-Qualified Stock Option (right to buy)
Common Stock
27.02K shares
Shares
−27.02K
Strike price
0.9489
Held after
270.22K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) Direct | Common Stock13.17K shares | 12/29/2022 | M · Option Exercise | −13.17K | 0.9489 | — | 311.08K |
| Non-Qualified Stock Option (right to buy) Direct | Common Stock12K shares | 12/30/2022 | M · Option Exercise | −12K | 0.9489 | — | 299.08K |
| Non-Qualified Stock Option (right to buy) Direct | Common Stock800.00 shares | 12/30/2022 | M · Option Exercise | −800.00 | 0.9489 | — | 298.28K |
| Non-Qualified Stock Option (right to buy) Direct | Common Stock1.05K shares | 12/30/2022 | M · Option Exercise | −1.05K | 0.9489 | — | 297.24K |
| Non-Qualified Stock Option (right to buy) Direct | Common Stock27.02K shares | 1/3/2023 | M · Option Exercise | −27.02K | 0.9489 | — | 270.22K |